Irisin Mitigates Microglial Inflammation Induced by β-Amyloid through the miR-451a/TLR4/NLRP3 Pathway - Top-Institutions - MDSpire

Irisin Mitigates Microglial Inflammation Induced by β-Amyloid through the miR-451a/TLR4/NLRP3 Pathway

  • By

  • Roberta Mancuso

  • Marina Saresella

  • Riccardo Nuzzi

  • Simone Agostini

  • Ivana Marventano

  • Ambra Hernis

  • Francesca La Rosa

  • Federica Piancone

  • Mario Clerici

  • April 23, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neuroinflammation
    • Alzheimer's Disease
    • Molecular Neuroscience

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neuroimmunology
    • Alzheimer's Disease
    • Molecular Biology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Neuroscience
    • Neurodegeneration
    • Immunology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Inflammation

  • #5

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Neuroscience
    • Neuroinflammation
    • Alzheimer's Disease

Original Source(s)

Irisin Mitigates Microglial Inflammation Induced by β-Amyloid through the miR-451a/TLR4/NLRP3 Pathway

  • by Roberta Mancuso, Marina Saresella, Riccardo Nuzzi, Simone Agostini, Ivana Marventano, Ambra Hernis, Francesca La Rosa, Federica Piancone, Mario Clerici

  • April 23, 2026

Related Content

Editorial: Transforming dementia caregiving through assistive technologies

Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia

Editorial: Unraveling protein misfolding and innate immunity in neurodegenerative diseases